ART: NEW DATA AND NEW INSIGHTS
MULTIPLE DAILY DOSES OF MK-8591 AS LOW AS 0.25 MG ARE EXPECTED TO SUPPRESS HIV
Randolph P Matthews
Merck Research Laboratories, North Wales, PA, USA
ORAL ABSTRACT MODERATOR
Giovanni Di Perri
University of Torino, Torino, Italy
ORAL ABSTRACT MODERATOR
Michelle S Cespedes
Icahn School of Medicine at Mt Sinai, New York, NY, USA